Introducing the Iron-deficiency Expert Board

February 21, 2013

Staying on top in a competitive world requires constant vigilance and front-running insight and knowledge.

Therefore, we are deeply pleased to introduce the Uniferon Iron-deficiency Expert Board: A selected group of the world's most respected iron/growth experts.

The International Iron Expert Board was founded in 2012 and consists of:

Professor Jens Peter Nielsen, University of Copenhagen
Professor Guy-Pierre Martineau, University of Toulouse
Professor Tore Framstad, Norwegian School of Medicine Senior
Project Manager Marie Erika Busch, Pig Research Centre
Professor Robert Friendship, University of Guelph

The purpose of the Iron-deficiency Expert Board is very clear: To create a stronger focus on iron as a significant factor in piglet health, especially beyond the present day use.

This is done in order to ensure adequate iron supplement for all piglets (avoiding an "iron gap") and to understand anaemia in general and the relation between anaemia and growth.

The Iron-deficiency Expert Board is presently working on a poster on assessment of anaemia prophylaxis in piglets for the European Symposium of Porcine Health Management in Edinburgh in May 2013. The group is also working on two protocols: A herd diagnostics protocol and an optimized care protocol.

At Pharmacosmos, we are convinced that the board will contribute significantly to the iron/growth discussion on an international scale, while providing very tangible and hands-on input to our continuous work in the field of injectable iron supplementation and best practice.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.